Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Convalescent Plasma with Supportive Care: 200-600 mL convalescent plasma;single dose or into divided doses;intravenous for 1 to 7 days along with supportive careControl Intervention1: Random donor Plasma with Supportive Care: 200-600 mL random donor plasma;single dose or into divided doses;intravenous for 1 to 7 days along with supportive care. Supportive Care will be based on symptomatic treatment", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Convalescent Plasma with Supportive Care: 200-600 mL convalescent plasma;single dose or into divided doses;intravenous for 1 to 7 days along with supportive care", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Random donor Plasma with Supportive Care: 200-600 mL random donor plasma;single dose or into divided doses;intravenous for 1 to 7 days along with supportive care. Supportive Care will be based on symptomatic treatment", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 322, "treatment_name": "Convalescent plasma", "treatment_type": "Convalescent plasma", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 322, "treatment_name": "Convalescent plasma", "treatment_type": "Convalescent plasma", "pharmacological_treatment": "Biological treatment"}]

Nov. 13, 2021, 5:33 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

Oct. 26, 2020, 8:29 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Convalescent Plasma with Supportive Care: 200-600 mL convalescent plasma;single dose or into divided doses;intravenous for 1 to 7 days along with supportive careControl Intervention1: Random donor Plasma with Supportive Care: 200-600 mL random donor plasma;single dose or into divided doses;intravenous for 1 to 7 days along with supportive care. Supportive Care will be based on symptomatic treatment", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Convalescent Plasma with Supportive Care: 200-600 mL convalescent plasma;single dose or into divided doses;intravenous for 1 to 7 days along with supportive care", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Random donor Plasma with Supportive Care: 200-600 mL random donor plasma;single dose or into divided doses;intravenous for 1 to 7 days along with supportive care. Supportive Care will be based on symptomatic treatment", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]